Key Insights

Highlights

Success Rate

96% trial completion (above average)

Published Results

31 trials with published results (13%)

Research Maturity

164 completed trials (69% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.0%

7 terminated out of 237 trials

Success Rate

95.9%

+9.4% vs benchmark

Late-Stage Pipeline

12%

28 trials in Phase 3/4

Results Transparency

19%

31 of 164 completed with results

Key Signals

31 with results96% success

Data Visualizations

Phase Distribution

179Total
Not Applicable (126)
Early P 1 (2)
P 1 (12)
P 2 (11)
P 3 (20)
P 4 (8)

Trial Status

Completed164
Unknown23
Recruiting19
Active Not Recruiting11
Withdrawn7
Terminated7

Trial Success Rate

95.9%

Benchmark: 86.5%

Based on 164 completed trials

Clinical Trials (237)

Showing 20 of 20 trials
NCT06511908Phase 2Recruiting

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

NCT06810076Not ApplicableActive Not Recruiting

Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care

NCT07466875Not ApplicableRecruiting

Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients

NCT05318976Phase 2Completed

A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation

NCT05508789Phase 3Recruiting

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

NCT03353805CompletedPrimary

Hospital Cohort Survey of Public Health Post-attack of July 14, 2016

NCT05854160Not ApplicableRecruiting

Stimulation-Induced Changes in Fronto-Limbic Network

NCT02836080Not ApplicableActive Not RecruitingPrimary

Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT)

NCT06580860RecruitingPrimary

Psychiatric Multi-omics and Neuroimaging Project

NCT07446218Not ApplicableNot Yet RecruitingPrimary

Pharmacist-led Interventions in Psychiatric Patients

NCT07443033Not Yet Recruiting

Psychosocial Factors in Dual Diagnosis in a General Hospital

NCT05522387Phase 2Terminated

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

NCT07387757Not ApplicableNot Yet RecruitingPrimary

Exergames in Mental Health

NCT06387290Phase 3Recruiting

Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits

NCT06614842Not ApplicableWithdrawn

Common Factors Group Psychotherapy for General Mental Health Concerns

NCT06012149Not ApplicableActive Not RecruitingPrimary

Braining: Implementation of Physical Exercise for Patients in Specialist Psychiatry

NCT02744989Not ApplicableCompletedPrimary

STIM'ZO : Examining tDCS as an add-on Treatment for Persistent Symptoms in Schizophrenia

NCT04289142Phase 4Recruiting

Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients

NCT05758285Completed

Using Responsible Artificial Intelligence (AI) to Predict Online Therapy Outcome and Engagement

NCT05738486Phase 3Active Not Recruiting

A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)

Scroll to load more

Research Network

Activity Timeline